Obesity Clinical Development Pipeline Muscle and Body Composition Other assets focused on preventing muscle loss in combination with incretin mimetics include Regenerons Phase 2 trevogrumab (myostatin) + garetosmab (ActA) combination, BioAges Phase 2 azelaprag (APJ), and Scholar Rocks Phase 2 apitegromab (myostatin)
Wu J, Tang Q, Ren X, Zheng F, He C, Chai X, Li L, Hann SS (2019) Reciprocal interaction of HOTAIR and SP1 together enhance the ability of Xiaoji decoction and gefitinib to inhibit EP4 expression
IN THIS EPISODE - What a peptide actually is, and why your GLP-1 is NOT the same thing as BPC-157 or TB-500 - The seven peptides the FDA is reviewing: BPC-157, KPV, TB-500 (the "Wolverine complex"), MOTS-c, DSIP, Semax, and Epitalon - The "funding gap" why peptides that can't be patented never get human clinical trials - Six things the FDA worries about in an unlabeled vial, from identity and purity to the cancer/angiogenesis risk - The two questions that tell you if a peptide provider is legitimate (503A/B pharmacies and third-party certificates of analysis) ABOUT THE GUEST Tanna Donalson is a Physician Assistant and Owner of Redbud Medical in Denver Colorado
Increased intake of vegetable oil rich in n-6 PUFA enhances allergic symptoms and prevents oral tolerance induction in whey-allergic mice
